Table 3.
Prevalence of extended-spectrum β-lactamases (ESBLs) among E. coli in specific allocation.
| Study | Site and setting | Study period | No of isolates | Prevalence of ESBL-producing E. coli |
|---|---|---|---|---|
| Hsueh et al. (2001) | ICUs in five centers in northern and southern Taiwan | 2000 | 177 | 11.9% |
| Shu et al. (2010) | ICUs in 1 medical center in northern Taiwan | 2001–2007 | NA | 35.9% (peak in medical ICU in 2016) |
| Jean et al. (2009) | ICUs in 10 medical centers in northern, central and southern Taiwan | 2005 | 160 | 14% |
| Lee C. M. et al. (2009) | Respiratory care center in a medical center in northern Taiwan | 2001–2002 | 51 | 31.4% |
| Lin et al. (2013) | Respiratory care wards in northern Taiwan | 2006–2007 | NA | 39.5% |
| Liu et al. (2016) | Nursing home in southern Taiwan | 2009–2011 | 288 | 52.7% (urine), 69.6% (sputum), 60.5% (blood) |